Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oxfendazole. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110903247B reveals a urea peroxide oxidation method for oxfendazole, significantly reducing impurity B and enhancing safety for veterinary pharmaceutical manufacturing.
Patent CN106380452A reveals solvent reduction technology for oxfendazole. Enhances supply chain reliability and cost reduction in veterinary drugs manufacturing.